Treatment with β-sitosterol resulted in a reduction in the amount of inflammation-related mRNA and protein in atopic dermatitis lesions and in the levels of histamine, IgE, and interleukin-4 in the serum [82,83]. Here, IL4 is linked to atopic eczema.